China
· Delayed Price · Currency is CNY Yifan Pharmaceutical Company Description
Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.
It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations.
The company also focuses on hematologic maliganancies, inflammatory, endocrinology/metabolic, dermatological, gynecologic, and pediatric diseases, etc. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016.
Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
| Country | China |
| Founded | 2000 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 4,230 |
| CEO | Xian Feng Cheng |
Contact Details
Address: No. 50, Qinshan Hangzhou, Zhejiang Province 311300 China | |
| Phone | 86 40 0180 2019 |
| Website | yifanyy.com |
Stock Details
| Ticker Symbol | 002019 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001K65 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xian Feng Cheng | Chairman of the Board of Directors and GM |
| Dawei Zhang | Financial Director |
| Xing Lin | Deputy GM and Director |
| Deqi Feng | Board Secretary, Deputy GM and Director |
| Ximing Li | Deputy General Manager |
| Yuhong Geng | Deputy General Manager |
| Kai Wang | Head of Accounting |
| William Tan | Director of Sales Team |